MDB Capital Holdings (MDBH) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

MDBH MDB Capital Holdings

Watchlist

10.675
+2.895+37.21%

Close Jul 19 16:00 ET

11.770
+1.095+10.26%

Post 19:58 ET

99.23MMarket Cap-8062P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

MDB Capital Announces Record Date Of July 22, 2024 For IPO Of 4.3M Shares Of Common Stock For Invizyne Technologies At A Price Of $4/Share
Record date of July 22, 2024 set for allocation preferencesClosing and trading expected on NASDAQ on or before August 15Addison, Texas, July 11, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (
BenzingaJul 11 16:10 ET
Express News | MDB Capital Announces Record Date and Expected Timing for Initial Public Offering for Invizyne Technologies
ReutersJul 11 16:05 ET
Express News | MDB Capital And Mayo Clinic Collaborate To Advance Anti-Senescence Platform
BenzingaJul 8 16:17 ET
Express News | MDB Capital Collaborates With Mayo Clinic to Advance Anti-Senescence Platform
ReutersJul 8 16:16 ET
MDB Capital Holdings Board Now Comprises Eight Members >MDBH
MDB Capital Holdings Board Now Comprises Eight Members >MDBH
Dow JonesJun 20 09:15 ET
Express News | MDB Capital Expands Board, Appoints Daniel Torpey as New Director
ReutersJun 20 09:15 ET

Comments

Jaguar8

Jul 8 15:17

NEWS

$MDB Capital Holdings(MDBH.US)$
MDB Capital Collaborates with Mayo Clinic to Advance Anti-Senescence Platform
MDB Capital Holdings (NASDAQ: MDBH) has announced a collaboration with Mayo Clinic to develop a small molecule anti-senescence platform. This partnership targets research in longevity and the prevention of age-related diseases by eliminating senescent cells, which are linked to chronic low-grade inflammation and various age-related diseases, including fibrosis. Mayo Clinic's studies ...